Eli Lilly (LLY.US) faces lawsuit over weight-loss drug ads, accused by Novo Nordisk (NVO.US) of "misleading marketing"
智通财经2026/07/21 14:06Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
Golden Ten Data APP has learned that as competition between two pharmaceutical giants intensifies, Novo Nordisk (NVO.US) has filed a lawsuit in the US federal court, accusing Eli Lilly (LLY.US) of misleading advertising for its bestselling weight-loss drug Zepbound and diabetes injection drug Mounjaro.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
Crypto prices
More
Bitcoin
BTC
$76,738.8
-0.71%
Ethereum
ETH
$2,476.13
-2.49%
Tether USDt
USDT
$0.9996
-0.01%
BNB
BNB
$715.38
-2.78%
XRP
XRP
$1.34
-2.13%
USDC
USDC
$0.9999
+0.01%
Solana
SOL
$99.77
-2.14%
TRON
TRX
$0.3409
+0.01%
Hyperliquid
HYPE
$77.61
-3.29%
Zcash
ZEC
$1,091.63
-5.52%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now